Name

UC Davis Comprehensive Cancer Center

Legal name

The Regents of the University of California

Website

https://cancer.ucdavis.edu

Company type

Public

Founded year

2012

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Oncology Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Offices of Physicians (62111), Diagnostic Imaging Centers (621512), Other Outpatient Care Centers (62149)

SIC

Services-Hospitals (8060), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM), Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Medical Oncology (HLAKAFAB), Surgical Oncology (HLAKAFAG)

Keywords

• Oncology services
• Cancer treatment
• Clinical trials
• Cancer research
• Pediatric oncology

Headquarters

HQ city

Sacramento

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Others

Revenue model

1. Clinical Care and Treatment Services: Revenue generated from providing cancer diagnosis, treatment, and care services to patients through insurance reimbursements, Medicare/Medicaid, and self-pay arrangements
2. Clinical Research and Trials: Grant funding from NCI, pharmaceutical company-sponsored trials, and government research funding supporting clinical research operations
3. Professional Services and Referrals: Specialist consultation services, second opinions, and treatment planning for referred patients from regional healthcare providers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

UC Davis Comprehensive Cancer Center is an NCI-designated Comprehensive Cancer Center providing comprehensive cancer care spanning diagnosis, treatment, and survivorship, along with clinical trials, translational research, and education/training programs. It serves the Sacramento region and Northern California through its main Sacramento facility and the affiliated Cancer Care Network, offering specialty programs in radiation oncology, surgical oncology, gynecologic oncology, urologic oncology, hematology/medical oncology, stem cell transplant, hereditary cancer, and pediatric oncology. The center also operates research programs, shared scientific resources, and community outreach initiatives.

Product overview

UC Davis Comprehensive Cancer Center is a comprehensive cancer care center offering a unified platform of clinical services, research programs, and patient support. The portfolio includes adult, pediatric, and adolescent/young adult cancer care services; 10 specialty programs (Gynecologic Oncology, Hematology and Medical Oncology, Hereditary Cancer Program, Pediatric Oncology, Radiation Oncology, Sickle Cell Program, Stem Cell Transplant, Surgical Oncology, Urologic Oncology); clinical support services (Laboratory Services, Oncology Pharmacy Services, Medical Interpreting, In-home Care); and patient support services (Support Groups, Patient and Family Learning Center). Research is organized into 4 programs (Biomedical Technology, Cancer Therapeutics, Integrated Cancer Biology, Population Sciences and Cancer Control) supported by 8 shared resources (Biorepository, Biostatistics, Flow Cytometry, Genomics, Immune Modeling/Analysis/Diagnostics, In Vivo Translational Imaging, Molecular Pharmacology and Chemical Biology, Mouse Biology). Community outreach includes the Cancer Care Network, Office of Community Outreach and Engagement, and SCOPE program. Education spans programs for high school students through early career faculty. The center is designated by the National Cancer Institute as one of approximately 59 comprehensive cancer centers in the United States.

Differentiator

Problem solved

Functional benefit

Products and services

• Adult Cancer Care Comprehensive cancer care for adult patients covering diagnosis, treatment, and support services for a wide range of cancer types.
• Pediatric Cancer Care Specialized cancer treatment and family-centered support services for pediatric patients.
• Adolescents and Young Adults (AYA) Cancer Care Cancer care services tailored for adolescents and young adults, including fertility preservation, psychosocial support, and educational/career continuity.
• Clinical Trials Access to new cancer treatments and research studies, with over 200 active trials available for patient enrollment.
• Gynecologic Oncology Specialized care for gynecologic cancers including cervical, ovarian, and uterine cancers.
• Hematology and Medical Oncology Treatment of blood disorders and cancers using medication-based therapies.
• Hereditary Cancer Program Genetic counseling and testing for inherited cancer risk assessment.
• Pediatric Oncology Specialized cancer treatment services for children.
• Radiation Oncology Cancer treatment using targeted radiation therapy.
• Sickle Cell Program Specialized program for sickle cell disease management.
• Stem Cell Transplant Bone marrow and stem cell transplantation services for eligible patients.
• Surgical Oncology Surgical treatment of cancers.
• Urologic Oncology Treatment of cancers affecting the urinary tract and male reproductive organs.
• Laboratory Services Diagnostic laboratory testing for cancer diagnosis and monitoring.
• Oncology Pharmacy Services Specialized pharmacy services for cancer medications and treatments.
• Medical Interpreting Language interpretation services for oncology patients.
• In-home Care and Respite Care Care services provided in patient homes and respite support for families.
• Support Groups Support groups for cancer patients and their families.
• Patient and Family Learning Center Educational resources for patients and families about cancer.
• Biomedical Technology Program Research program focused on biomedical technology for cancer detection and treatment.
• Cancer Therapeutics Program Research program developing new cancer treatments and therapies.
• Integrated Cancer Biology Program Research program studying cancer biology and mechanisms.
• Population Sciences and Cancer Control Program Research program focused on cancer prevention, control, and population health.
• Biorepository Repository for biological samples supporting cancer research.
• Biostatistics Statistical support and analysis for cancer research.
• Flow Cytometry Cell analysis technology for cancer research.
• Genomics Genetic and genomic analysis services for cancer research.
• Immune Modeling, Analysis and Diagnostics Immunological analysis and diagnostic services for cancer research.
• In Vivo Translational Imaging Live animal imaging for cancer research translation.
• Molecular Pharmacology and Chemical Biology Drug development and chemical biology research services.
• Mouse Biology Mouse models for cancer research.
• Education and Training Programs Training programs for high school students, undergraduates, graduate students, postdoctorates, health professionals, and early career faculty in cancer research.
• Cancer Care Network Network of affiliated sites extending cancer care to the broader community across Northern California.
• Office of Community Outreach and Engagement Community outreach programs and cancer awareness initiatives.
• Cancer Center Office of Population Health Population health initiatives for cancer prevention and control.
• Sacramento Citywide Oncology Phase I Program (SCOPE) Early-phase clinical trial program expanding access to novel cancer therapies in the Sacramento area.

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core.

• National Comprehensive Cancer Network (NCCN)coreStrategic or Co-development PartnerUC Davis Comprehensive Cancer Center is a member of the NCCN, an alliance of the world's leading cancer centers. This membership provides access to evidence-based treatment guidelines, best practices, and collaborative research opportunities across premier cancer institutions.
• University of California Health SystemcoreStrategic or Co-development PartnerAs part of the University of California Health system, UC Davis Comprehensive Cancer Center collaborates with other UC medical centers on research, shares best practices, and participates in system-wide initiatives.
• UC Davis School of MedicinecoreStrategic or Co-development PartnerIntegration with UC Davis School of Medicine enables physician training, collaborative research, and access to academic medicine resources.
• Cancer Care Network AffiliatescoreChannel Partner/ Reseller/ DistributorRegional healthcare facilities affiliated with the Cancer Care Network that provide local access to cancer care services, extending the center's reach into communities throughout Northern California.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• USC Norris Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center in Los Angeles; comparable academic cancer center offering multidisciplinary oncology care, clinical trials, and population health research.
• UCLA Jonsson Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center within the University of California system; sister UC institution that competes for research funding, system-wide initiatives, and California oncology patients.
• Fred Hutchinson Cancer Center: NCI-designated Comprehensive Cancer Center in Seattle with a strong translational research and bone marrow transplant legacy, comparable to UC Davis's research and stem cell transplant program.
• City of Hope Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center in Southern California with a strong translational research and Phase I trial focus, comparable to UC Davis's research and clinical trial portfolio.
• Dana-Farber Cancer Institute: NCI-designated Comprehensive Cancer Center affiliated with Harvard Medical School; comparable in research intensity, clinical trial portfolio, and academic medicine integration.
• Stanford Cancer Institute: NCI-designated Comprehensive Cancer Center at Stanford University, in close geographic proximity to UC Davis; competes for complex oncology cases, clinical trials, and top physician-researcher talent in Northern California.
• Mayo Clinic Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center integrated within Mayo Clinic; comparable in offering multidisciplinary oncology care, Phase I trials, and population-scale clinical research.
• Memorial Sloan Kettering Cancer Center: One of the oldest and largest NCI-designated Comprehensive Cancer Centers in the U.S.; benchmarks the gold standard for clinical oncology volume, research output, and brand reputation that UC Davis competes against.
• MD Anderson Cancer Center: The largest NCI-designated Comprehensive Cancer Center in the U.S., part of the University of Texas system; comparable academic-public governance model and the benchmark for oncology research and clinical excellence.
• UCSF Helen Diller Family Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center in Northern California; competes directly with UC Davis for oncology referrals, clinical trial enrollment, and research funding within the same California catchment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/UCDavisHealth
• YouTubeyoutube.com/ucdavishealth
• Facebookfacebook.com/UCDavisCancer
• LinkedInlinkedin.com/company/uc-davis-comprehensive-cancer-center
• Instagraminstagram.com/ucdaviscancer

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UC Davis Comprehensive Cancer Center